New combo therapy aims to wipe out esophageal cancer before surgery
NCT ID NCT04028167
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial is testing a two-step treatment for esophageal cancer. First, patients receive a chemotherapy combination called FLOT, followed by chemoradiation (chemo plus radiation). After that, they have surgery to remove the tumor. The goal is to see if this approach leads to a complete disappearance of cancer in the removed tissue. The study involves 40 adults with resectable cancer of the esophagus or gastroesophageal junction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FLOT chemotherapy (docetaxel, oxaliplatin, leucovorin, 5-FU) followed by chemoradiation with carboplatin and paclitaxel
What this could lead to
If successful, this treatment sequence could increase the number of patients whose cancer disappears completely before surgery, potentially improving long-term survival.
What could go wrong
This is a small, early-phase trial with only 40 participants, so results may not apply broadly. Chemotherapy and radiation have significant side effects, and the regimen may not improve outcomes over standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA ESOPHAGUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCHealth Northern Colorado - Greeley Hospital
Greeley, Colorado, 80634, United States
-
UCHealth Northern Colorado - Harmony Campus
Fort Collins, Colorado, 80528, United States
-
UCHealth Northern Colorado - Poudre Valley Hospital
Fort Collins, Colorado, 80524, United States
-
UCHealth Northern Colorado Medical Center of the Rockies
Loveland, Colorado, 80538, United States
-
UCHealth Southern Colorado - Memorial Hospital Central
Colorado Springs, Colorado, 80909, United States
-
UCHealth Southern Colorado - Memorial Hospital North
Colorado Springs, Colorado, 80920, United States
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States